313 related articles for article (PubMed ID: 28662873)
1. Asymptomatic Hypertrophic Cardiomyopathy: Diagnosis and Therapy.
Luis Fuentes V; Wilkie LJ
Vet Clin North Am Small Anim Pract; 2017 Sep; 47(5):1041-1054. PubMed ID: 28662873
[TBL] [Abstract][Full Text] [Related]
2. The Feline Cardiomyopathies: 2. Hypertrophic cardiomyopathy.
Kittleson MD; Côté E
J Feline Med Surg; 2021 Nov; 23(11):1028-1051. PubMed ID: 34693811
[TBL] [Abstract][Full Text] [Related]
3. Feline Congestive Heart Failure: Current Diagnosis and Management.
Côté E
Vet Clin North Am Small Anim Pract; 2017 Sep; 47(5):1055-1064. PubMed ID: 28647113
[TBL] [Abstract][Full Text] [Related]
4. Utility of measuring plasma N-terminal pro-brain natriuretic peptide in detecting hypertrophic cardiomyopathy and differentiating grades of severity in cats.
Wess G; Daisenberger P; Mahling M; Hirschberger J; Hartmann K
Vet Clin Pathol; 2011 Jun; 40(2):237-44. PubMed ID: 21434959
[TBL] [Abstract][Full Text] [Related]
5. The Feline Cardiomyopathies: 1. General concepts.
Kittleson MD; Côté E
J Feline Med Surg; 2021 Nov; 23(11):1009-1027. PubMed ID: 34693806
[TBL] [Abstract][Full Text] [Related]
6. Prognostic indicators in cats with hypertrophic cardiomyopathy.
Payne JR; Borgeat K; Connolly DJ; Boswood A; Dennis S; Wagner T; Menaut P; Maerz I; Evans D; Simons VE; Brodbelt DC; Luis Fuentes V
J Vet Intern Med; 2013; 27(6):1427-36. PubMed ID: 24134821
[TBL] [Abstract][Full Text] [Related]
7. Risk factors associated with sudden death vs. congestive heart failure or arterial thromboembolism in cats with hypertrophic cardiomyopathy.
Payne JR; Borgeat K; Brodbelt DC; Connolly DJ; Luis Fuentes V
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S318-28. PubMed ID: 26776589
[TBL] [Abstract][Full Text] [Related]
8. Screening for hypertrophic cardiomyopathy in cats.
Häggström J; Luis Fuentes V; Wess G
J Vet Cardiol; 2015 Dec; 17 Suppl 1():S134-49. PubMed ID: 26776573
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a sensitive cardiac troponin I assay as a screening test for the diagnosis of hypertrophic cardiomyopathy in cats.
Hertzsch S; Roos A; Wess G
J Vet Intern Med; 2019 May; 33(3):1242-1250. PubMed ID: 30990935
[TBL] [Abstract][Full Text] [Related]
10. NT-proBNP measurement fails to reliably identify subclinical hypertrophic cardiomyopathy in Maine Coon cats.
Singh MK; Cocchiaro MF; Kittleson MD
J Feline Med Surg; 2010 Dec; 12(12):942-7. PubMed ID: 21036088
[TBL] [Abstract][Full Text] [Related]
11. Left atrial size, atrial function and left ventricular diastolic function in cats with hypertrophic cardiomyopathy.
Linney CJ; Dukes-McEwan J; Stephenson HM; López-Alvarez J; Fonfara S
J Small Anim Pract; 2014 Apr; 55(4):198-206. PubMed ID: 24506774
[TBL] [Abstract][Full Text] [Related]
12. Effect of feline characteristics on plasma N-terminal-prohormone B-type natriuretic peptide concentration and comparison of a point-of-care test and an ELISA test.
Hanås S; Holst BS; Höglund K; Häggström J; Tidholm A; Ljungvall I
J Vet Intern Med; 2020 May; 34(3):1187-1197. PubMed ID: 32200578
[TBL] [Abstract][Full Text] [Related]
13. The effect of atenolol on NT-proBNP and troponin in asymptomatic cats with severe left ventricular hypertrophy because of hypertrophic cardiomyopathy: a pilot study.
Jung SW; Kittleson MD
J Vet Intern Med; 2011; 25(5):1044-9. PubMed ID: 21781160
[TBL] [Abstract][Full Text] [Related]
14. Advances in feline cardiomyopathy.
Bond BR; Fox PR
Vet Clin North Am Small Anim Pract; 1984 Sep; 14(5):1021-38. PubMed ID: 6388131
[No Abstract] [Full Text] [Related]
15. Feline hypertrophic cardiomyopathy: an update.
Baty CJ
Vet Clin North Am Small Anim Pract; 2004 Sep; 34(5):1227-34. PubMed ID: 15325479
[TBL] [Abstract][Full Text] [Related]
16. Multicenter evaluation of plasma N-terminal probrain natriuretic peptide (NT-pro BNP) as a biochemical screening test for asymptomatic (occult) cardiomyopathy in cats.
Fox PR; Rush JE; Reynolds CA; Defrancesco TC; Keene BW; Atkins CE; Gordon SG; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Macdonald KA; Lehmkuhl LB; Nguyenba TP; Sydney Moise N; Lefbom BK; Hogan DF; Oyama MA
J Vet Intern Med; 2011; 25(5):1010-6. PubMed ID: 21985136
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.
Michałek M; Tabiś A; Pasławska U; Noszczyk-Nowak A
BMC Vet Res; 2020 Jan; 16(1):26. PubMed ID: 32000761
[TBL] [Abstract][Full Text] [Related]
18. Risk indictors in cats with preclinical hypertrophic cardiomyopathy: a prospective cohort study.
Ironside VA; Tricklebank PR; Boswood A
J Feline Med Surg; 2021 Feb; 23(2):149-159. PubMed ID: 32696726
[TBL] [Abstract][Full Text] [Related]
19. Biomarker changes with systolic anterior motion of the mitral valve in cats with hypertrophic cardiomyopathy.
Seo J; Payne JR; Novo Matos J; Fong WW; Connolly DJ; Luis Fuentes V
J Vet Intern Med; 2020 Sep; 34(5):1718-1727. PubMed ID: 32822105
[TBL] [Abstract][Full Text] [Related]
20. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
Hsu A; Kittleson MD; Paling A
J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
